Drugs / G3215
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02692040 | Jan 2015 → Jan 2019 | diabetes mellitus, obesity disorder | Imperial College London | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G3215 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02692040 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL6068605 ↗ |
| Route | Subcutaneous | “G3215 multiple dose, subcutaneous injection” NCT02692040 ↗ |